APA

Harnoss J. M., Gebhardt J. M., Radhakrishnan P., Leowardi C., Burmeister J., Halligan D. N., Yuan S., Kennel K. B., Strowitzki M. J., Schaible A., Lasitschka F., Taylor C. T. & Schneider M. (20201023). Prolyl Hydroxylase Inhibition Mitigates Pouchitis. : Inflammatory bowel diseases.

Chicago

Harnoss Jonathan M, Gebhardt Jasper M, Radhakrishnan Praveen, Leowardi Christine, Burmeister Julius, Halligan Doug N, Yuan Shuai, Kennel Kilian B, Strowitzki Moritz J, Schaible Anja, Lasitschka Felix, Taylor Cormac T and Schneider Martin. 20201023. Prolyl Hydroxylase Inhibition Mitigates Pouchitis. : Inflammatory bowel diseases.

Harvard

Harnoss J. M., Gebhardt J. M., Radhakrishnan P., Leowardi C., Burmeister J., Halligan D. N., Yuan S., Kennel K. B., Strowitzki M. J., Schaible A., Lasitschka F., Taylor C. T. and Schneider M. (20201023). Prolyl Hydroxylase Inhibition Mitigates Pouchitis. : Inflammatory bowel diseases.

MLA

Harnoss Jonathan M, Gebhardt Jasper M, Radhakrishnan Praveen, Leowardi Christine, Burmeister Julius, Halligan Doug N, Yuan Shuai, Kennel Kilian B, Strowitzki Moritz J, Schaible Anja, Lasitschka Felix, Taylor Cormac T and Schneider Martin. Prolyl Hydroxylase Inhibition Mitigates Pouchitis. : Inflammatory bowel diseases. 20201023.